Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8085765 | 0.99 | GRIN1 (0.65) | GRIN1 | |
| Bromide SCHEMBL3683185 | 0.86 | GRIN1 (0.57) | GRIN1 | |
| Bromide SCHEMBL8085837 | 0.85 | GRIN1 (0.73) | GRIN1 | |
| SCHEMBL27513153 | 0.85 | GRIN1 (0.62) | GRIN1 | |
| SCHEMBL8498041 | 0.84 | GRIN1 (0.61) | GRIN1 | |
| SCHEMBL8570277 | 0.84 | GRIN1 (0.58) | GRIN1 | |
| Bromide SCHEMBL6652922 | 0.84 | GRIN1 (0.67) | GRIN1 | |
| SCHEMBL8500263 | 0.84 | GRIN1 (0.64) | GRIN1 | |
| SCHEMBL8500945 | 0.84 | GRIN1 (0.61) | GRIN1 | |
| SCHEMBL8571578 | 0.84 | GRIN1 (0.74) | GRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6080743-A | AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS | NOVARTIS AG (CH) | 2000-06-27 | — | — | US | disclosed |
| EP-0853617-A1 | NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES | Novartis AG (CH) | 1998-07-22 | — | — | EP | disclosed |
| WO-1997008155-A1 | NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES | NOVARTIS AG (CH) | 1997-03-06 | — | — | WO | disclosed |